查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1651021

全球栓塞保護裝置市場

Embolic Protection Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球栓塞防護裝置市場規模將達到 21 億美元

2024 年全球栓塞防護裝置市場規模估計為 14 億美元，預計 2030 年將達到 21 億美元，2024 年至 2030 年的複合年成長率為 6.6%。遠端過濾器是報告中分析的細分市場，預計其複合年成長率為 7.6%，在分析期結束時達到 13 億美元。預計在分析期內，近端閉塞段的成長率為 4.3%。

美國市場規模估計為 3.999 億美元，中國市場預計複合年成長率為 6.2%

預計到 2024 年美國栓塞防護裝置市值將達到 3.999 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 3.268 億美元，2024-2030 年分析期間的複合年成長率為 6.2%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 6.3% 和 5.2%。在歐洲，德國的複合年成長率預計為 5.2%。

全球栓塞保護裝置市場 - 主要趨勢和促進因素摘要

栓塞保護裝置如何徹底改變心血管照護？

栓塞保護裝置 (EPD) 正在徹底改變心血管護理，顯著提高經皮冠狀動脈介入治療 (PCI) 和經導管主動脈瓣置換術(TAVR) 等手術的安全性和有效性。這些裝置專門用於捕獲和清除在干預過程中可能脫落的栓塞碎片，防止碎片進入血液並引起中風、心肌梗塞或器官損傷等併發症。因此，EPD 可以降低與心血管手術相關的主要風險之一，特別是對於更容易發生栓塞事件的高風險患者。此類設備的引入降低了手術併發症的發生率，改善了患者的治療效果，使得複雜的心血管手術更加安全、有效。隨著全球心血管疾病負擔不斷增加，栓塞保護裝置在確保患者安全和提高手術成功率方面的作用在現代心血管護理中變得越來越重要。

哪些創新正在提高栓塞防護裝置的功能？

栓塞保護裝置的創新正在透過設計、材料和與其他心血管技術的結合的進步來提高其功能。最重要的進展之一是這些設備的小型化，使得它們能夠以更高的精度和最小的干擾被放置在更小的血管中。這在頸動脈支架置入術等手術中尤其重要，因為該類手術中中風的風險很高，精確放置至關重要。此外，使用生物相容性聚合物和細網過濾器等先進材料，提高了 EPD 捕獲最小栓塞顆粒的能力，而不會阻礙血流。這導致了更有效、更患者友好的設備的開發，這些設備可以降低併發症的風險並縮短恢復時間。此外，栓塞保護裝置與血管內超音波(IVUS) 和光同調斷層掃瞄(OCT) 等影像技術的結合，可實現手術過程中的即時可視化。這種整合使臨床醫生能夠精確定位 EPD 並監測其性能，確保對栓塞事件提供最佳的保護。這些創新使得栓塞保護裝置更有效率、更容易使用和更安全，增強了其在廣泛心血管干預中的作用。

栓塞保護裝置如何影響病人結果和手術安全？

栓塞保護裝置可顯著降低心臟介入治療期間發生栓塞併發症的風險，對病患治療結果和手術安全有重大影響。在頸動脈支架置入術、TAVR和PCI等手術過程中，脫落的斑塊和血栓可能導致嚴重的併發症，包括中風和心臟病發作。透過在這些碎片到達大腦或冠狀動脈等關鍵部位之前將其捕獲，EPD 大大降低了這些不利事件的發生率。這種改進的安全性不僅改善了患者的治療效果，而且擴大了適合微創心血管手術的患者群體，包括先前被認為是高風險的患者。此外，使用 EPD 意味著患者會經歷更少的併發症，需要更少的加護治療，從而縮短住院時間並加快康復時間。對於醫療保健提供者來說，降低手術風險和相關併發症意味著提高整體成功率並降低醫療成本。栓塞保護裝置透過避免心血管護理中最重大的風險之一，在改善患者照護和使救生程序更安全方面發揮關鍵作用。

哪些趨勢推動了栓塞防護裝置市場的成長？

推動栓塞保護裝置市場成長的趨勢包括心血管疾病盛行率的不斷上升、微創手術的日益普及以及醫療技術的不斷進步。動脈粥狀硬化、心臟瓣膜疾病、頸動脈狹窄等疾病的發生率不斷上升，導致介入心臟病學的數量增加，從而推動了對 EPD 的需求。隨著世界人口老化和心血管疾病負擔增加，對安全有效的治療方案的需求變得越來越重要。向 TAVR 和頸動脈支架置入術等微創手術的轉變也刺激了市場成長。這些手術通常涉及栓塞事件的高風險，因此 EPD 對確保患者安全至關重要。此外，設備設計的不斷進步，例如開發具有增強過濾和改進輸送系統的下一代 EPD，正在擴大這些設備的應用和有效性。監管部門的核准和醫療保健專業人士對 EPD 益處的認知不斷提高，進一步促進了市場的擴張。這些趨勢強調了 EPD 在心血管醫學中日益成長的重要性，因為它們在提高關鍵干預措施的安全性和成功率方面繼續發揮關鍵作用。

部分

類型（遠端過濾器、近端閉塞、遠端閉塞）、應用（心血管疾病、周邊血管疾病、神經血管疾病）

受訪公司範例（42家值得關注的公司）

  • Abbott Laboratories, Inc.
  • Allium Medical Solutions Ltd.
  • AorticLab
  • Boston Scientific Corporation
  • Cardinal Health UK
  • Contego Medical, Inc.
  • Cordis, a Cardinal Health company
  • Duke Empirical, Inc.
  • Emboline Inc
  • Innovative Cardiovascular Solutions, LLC

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP11766

Global Embolic Protection Devices Market to Reach US$2.1 Billion by 2030

The global market for Embolic Protection Devices estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Distal Filter, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Proximal Occlusion segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$399.9 Million While China is Forecast to Grow at 6.2% CAGR

The Embolic Protection Devices market in the U.S. is estimated at US$399.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$326.8 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.3% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Global Embolic Protection Devices Market - Key Trends and Drivers Summarized

How Are Embolic Protection Devices Revolutionizing Cardiovascular Care?

Embolic protection devices (EPDs) are revolutionizing cardiovascular care by significantly enhancing the safety and efficacy of procedures like percutaneous coronary interventions (PCI) and transcatheter aortic valve replacements (TAVR). These devices are specifically designed to capture and remove embolic debris that may dislodge during these interventions, preventing it from traveling through the bloodstream and causing complications such as stroke, myocardial infarction, or organ damage. By doing so, EPDs mitigate one of the major risks associated with cardiovascular procedures, particularly in high-risk patients who are more susceptible to embolic events. The introduction of these devices has improved patient outcomes by reducing the incidence of procedural complications, thereby making complex cardiovascular treatments safer and more effective. As the global burden of cardiovascular disease continues to rise, the role of embolic protection devices in ensuring patient safety and enhancing procedural success is becoming increasingly important in modern cardiovascular care.

What Innovations Are Enhancing the Functionality of Embolic Protection Devices?

Innovations in embolic protection devices are enhancing their functionality through advancements in design, materials, and integration with other cardiovascular technologies. One of the most significant developments is the miniaturization of these devices, allowing them to be deployed in smaller blood vessels with greater precision and minimal disruption. This is particularly important in procedures like carotid artery stenting, where the risk of stroke is high and precise placement is crucial. Additionally, the use of advanced materials, such as biocompatible polymers and fine mesh filters, has improved the ability of EPDs to capture even the smallest embolic particles without impeding blood flow. This has led to the development of more effective and patient-friendly devices that reduce the risk of complications and improve recovery times. Furthermore, the integration of embolic protection devices with imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is enabling real-time visualization during procedures. This integration allows clinicians to accurately position EPDs and monitor their performance, ensuring optimal protection against embolic events. These innovations are making embolic protection devices more efficient, easier to use, and safer, enhancing their role in a wide range of cardiovascular interventions.

How Do Embolic Protection Devices Impact Patient Outcomes and Procedure Safety?

Embolic protection devices have a profound impact on patient outcomes and procedure safety by significantly reducing the risk of embolic complications during cardiovascular interventions. In procedures such as carotid artery stenting, TAVR, and PCI, the dislodgement of plaque or thrombus can lead to serious complications, including stroke or heart attack. By capturing this debris before it can travel to critical areas like the brain or coronary arteries, EPDs dramatically reduce the incidence of these adverse events. This improved safety profile not only enhances patient outcomes but also expands the pool of patients eligible for minimally invasive cardiovascular procedures, including those who were previously considered high-risk. Moreover, the use of EPDs can lead to shorter hospital stays and quicker recovery times, as patients experience fewer complications and require less intensive postoperative care. For healthcare providers, the reduction in procedural risks and associated complications translates into better overall success rates and potentially lower healthcare costs. By safeguarding against one of the most significant risks in cardiovascular interventions, embolic protection devices are playing a critical role in advancing patient care and improving the safety of life-saving procedures.

What Trends Are Driving Growth in the Embolic Protection Devices Market?

Several trends are driving growth in the embolic protection devices market, including the increasing prevalence of cardiovascular diseases, the growing adoption of minimally invasive procedures, and the continuous advancements in medical technology. The rising incidence of conditions such as atherosclerosis, heart valve diseases, and carotid artery stenosis is leading to an increase in the number of cardiovascular interventions, thereby boosting demand for EPDs. As the global population ages and the burden of cardiovascular diseases grows, the need for safe and effective treatment options is becoming more critical. The shift towards minimally invasive procedures, such as TAVR and carotid artery stenting, is also fueling market growth, as these procedures typically carry a higher risk of embolic events, making EPDs essential for ensuring patient safety. Moreover, ongoing advancements in device design, including the development of next-generation EPDs with enhanced filtration capabilities and improved delivery systems, are expanding the applications and effectiveness of these devices. Regulatory approvals and increasing awareness among healthcare providers about the benefits of EPDs are further contributing to market expansion. These trends underscore the growing importance of embolic protection devices in the field of cardiovascular medicine, as they continue to play a pivotal role in enhancing the safety and success of critical interventions.

SCOPE OF STUDY:

The report analyzes the Embolic Protection Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Distal Filter, Proximal Occlusion, Distal Occlusion); Application (Cardiovascular Diseases, Peripheral Vascular Diseases, Neurovascular Diseases)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories, Inc.
  • Allium Medical Solutions Ltd.
  • AorticLab
  • Boston Scientific Corporation
  • Cardinal Health UK
  • Contego Medical, Inc.
  • Cordis, a Cardinal Health company
  • Duke Empirical, Inc.
  • Emboline Inc
  • Innovative Cardiovascular Solutions, LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Embolic Protection Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Cardiovascular Diseases Drives Demand for Embolic Protection Devices
    • Increasing Adoption of Minimally Invasive Surgical Techniques Bolsters Market Growth
    • Rising Global Health Awareness and Healthcare Access Enhancing Market Opportunities
    • Economic Factors Influencing Healthcare Spending and Device Adoption
    • Development of Next-Generation Embolic Protection Devices for Neurovascular Applications
    • Increasing Incidence of Atrial Fibrillation and Stroke Risk Management
    • Market Influence of Aging Populations on Cardiovascular Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Distal Filter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Distal Filter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Distal Filter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Distal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Distal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Distal Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Proximal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Proximal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Proximal Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Peripheral Vascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Peripheral Vascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Peripheral Vascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Neurovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Neurovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Embolic Protection Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Embolic Protection Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • JAPAN
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • CHINA
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • EUROPE
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Embolic Protection Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Embolic Protection Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • GERMANY
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Rest of Europe 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Asia-Pacific 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of World 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030

IV. COMPETITION